{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:02:00Z","timestamp":1791993720295,"version":"4.4.0"},"reference-count":136,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chemotherapy and radiotherapy, among other gonadotoxic treatments, can significantly affect ovarian reserve and function, potentially leading to premature ovarian insufficiency (POI) and sterility. With the increasing survival rates among young female cancer patients, fertility preservation (FP) has become an essential aspect of cancer care. The decision to pursue FP depends on various factors, including patient age, ovarian reserve, the type of treatment, and its gonadotoxic potential. Several FP strategies are available, including oocyte, embryo, and ovarian tissue cryopreservation. While oocyte and embryo cryopreservation are the gold standard techniques, ovarian tissue cryopreservation and in vitro maturation (IVM) present viable alternatives for patients who cannot undergo ovarian stimulation or for whom stimulation is contraindicated. Despite significant advances within the FP practice, challenges remain in ensuring timely FP counseling, equitable access to services, and optimizing long-term reproductive outcomes. Continued research is needed to refine existing FP techniques, explore innovative approaches, and address ethical considerations in FP decision-making. This review explores current FP options, their clinical applications, and future directions to improve reproductive outcomes in young women undergoing gonadotoxic treatments.<\/jats:p>","DOI":"10.3390\/jcm14061912","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:31:42Z","timestamp":1741764702000},"page":"1912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["How to Preserve Fertility in Reproductive-Age Women with Cancer"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8115-0986","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Jaeck","sequence":"first","affiliation":[{"name":"Reproductive Biology Unit-CECOS, University Hospital of Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7484-7885","authenticated-orcid":false,"given":"Chlo\u00e9","family":"Depuydt","sequence":"additional","affiliation":[{"name":"Reproductive Biology Unit-CECOS, University Hospital of Bordeaux, 33000 Bordeaux, France"},{"name":"U1312-BRIC Team Biotherapies Genetics and Oncology-BioGO, Bordeaux University, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bernard","sequence":"additional","affiliation":[{"name":"U1312-BRIC Team Biotherapies Genetics and Oncology-BioGO, Bordeaux University, 33000 Bordeaux, France"},{"name":"Gynecological Surgery, Medical Gynecology and Reproductive Medicine Department, University Hospital of Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ammar","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Division, Louise, 33300 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Hock\u00e9","sequence":"additional","affiliation":[{"name":"Gynecological Surgery, Medical Gynecology and Reproductive Medicine Department, University Hospital of Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Carri\u00e8re","sequence":"additional","affiliation":[{"name":"Gynecological Surgery, Medical Gynecology and Reproductive Medicine Department, University Hospital of Bordeaux, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Chansel-Debordeaux","sequence":"additional","affiliation":[{"name":"Reproductive Biology Unit-CECOS, University Hospital of Bordeaux, 33000 Bordeaux, France"},{"name":"U1312-BRIC Team Biotherapies Genetics and Oncology-BioGO, Bordeaux University, 33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"ref_1","unstructured":"(2024, August 29). Cancer. Available online: https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_3","first-page":"188","article-title":"Incidence des Principaux Cancers en France M\u00e9tropolitaine en 2023 et Tendances Depuis 1990\/Main Cancers Incidence in Metropolitan France in 2023 and Trends Since 1990","volume":"12\u201313","year":"2023","journal-title":"Bull. Epid\u00e9miol. Hebd.\u2014BEH"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.esmoop.2021.100255","article-title":"Worldwide cancer statistics of adolescents and young adults in 2019: A systematic analysis of the Global Burden of Disease Study 2019","volume":"6","author":"You","year":"2021","journal-title":"ESMO Open"},{"key":"ref_5","unstructured":"(2024, August 27). Pr\u00e9servation de la Fertilit\u00e9 chez les Hommes et les Femmes Atteints d\u2019un Cancer\/Th\u00e9saurus, Janvier 2021. Available online: https:\/\/www.cancer.fr\/catalogue-des-publications\/preservation-de-la-fertilite-et-cancer-thesaurus."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: Mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-M\u00fcllerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Decanter, C., Elefant, E., Poirot, C., and Courbiere, B. (2024). What reproductive follow-up for adolescent and young women after cancer? A review. Reprod. Biomed. Online, 49.","DOI":"10.1016\/j.rbmo.2024.103891"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/dey250","article-title":"Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation","volume":"33","author":"Grosbois","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10815-019-01628-1","article-title":"Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue","volume":"37","author":"Masciangelo","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Erden, M., and Oktay, K.H. (2025). Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?. Hum. Reprod., 1\u20139.","DOI":"10.1093\/humrep\/deaf024"},{"key":"ref_12","first-page":"185ra62","article-title":"Cyclophosphamide Triggers Follicle Activation and \u201cBurnout\u201d; AS101 Prevents Follicle Loss and Preserves Fertility","volume":"5","author":"Roness","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1684\/bdc.2011.1471","article-title":"Agents alkylants","volume":"98","author":"Pourquier","year":"2011","journal-title":"Bull. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","article-title":"Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer","volume":"39","author":"Koyama","year":"1977","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/humrep\/deab035","article-title":"Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: Investigating dose-effect relationships in a European case-control study (PanCareLIFE)","volume":"36","author":"Byrne","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e31436","DOI":"10.1002\/pbc.31436","article-title":"Implications of Implementing Children\u2019s Oncology Group Risk Stratification to Patients with Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial","volume":"72","author":"Bisogno","year":"2025","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on Female Fertility Preservation, Anderson, R.A., Amant, F., Braat, D., D\u2019Angelo, A., Chuva de Sousa Lopes, S.M., Demeestere, I., Dwek, S., Frith, L., and Lambertini, M. (2020). ESHRE guideline: Female fertility preservation. Hum. Reprod. Open, 2020, hoaa052.","DOI":"10.1093\/hropen\/hoaa052"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.rbmo.2022.09.014","article-title":"Breast cancer treatment and ovarian function","volume":"46","author":"Yildiz","year":"2023","journal-title":"Reprod. Biomed. Online"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yin, W.W., Huang, C.C., Chen, Y.R., Yu, D.Q., Jin, M., and Feng, C. (2022). The effect of medication on serum anti-m\u00fcllerian hormone (AMH) levels in women of reproductive age: A meta-analysis. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-01065-9"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: Who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/humupd\/dmz041","article-title":"Do cancer therapies damage the uterus and compromise fertility?","volume":"26","author":"Griffiths","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S2213-8587(15)00008-X","article-title":"Effect of cancer treatment on hypothalamic\u2013pituitary function","volume":"3","author":"Crowne","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bulcan.2015.03.015","article-title":"Impact de la radioth\u00e9rapie sur la fertilit\u00e9 f\u00e9minine","volume":"102","author":"Mazeron","year":"2015","journal-title":"Bull. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bulcan.2017.11.001","article-title":"Pr\u00e9servation de la fertilit\u00e9 en canc\u00e9rologie","volume":"105","author":"Chaput","year":"2018","journal-title":"Bull. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10815-016-0721-5","article-title":"Ovarian stimulation in the luteal phase: Systematic review and meta-analysis","volume":"33","author":"Boots","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rbmo.2014.03.024","article-title":"Oocyte vitrification in the 21st century and post-warming fertility outcomes: A systematic review and meta-analysis","volume":"29","author":"Potdar","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.rbmo.2014.12.012","article-title":"Open versus closed systems for vitrification of human oocytes and embryos","volume":"30","author":"Vajta","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and Onco-fertility preservation: Factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/deac249","article-title":"Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: A systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation","volume":"38","author":"Fraison","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/humrep\/det268","article-title":"Emergency IVF for embryo freezing to preserve female fertility: A French multicentre cohort study","volume":"28","author":"Courbiere","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2016.09.041","article-title":"Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment","volume":"107","author":"Creux","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humrep\/dev325","article-title":"Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients","volume":"31","author":"Grynberg","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.fertnstert.2018.10.018","article-title":"Serum antim\u00fcllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation","volume":"111","author":"Sermondade","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/dew102","article-title":"What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?","volume":"31","author":"Sonigo","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10815-023-02739-6","article-title":"Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM","volume":"40","author":"Sellami","year":"2023","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10815-021-02168-3","article-title":"Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: A retrospective study of ten years of experience","volume":"38","author":"Mayeur","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Diaz, A.A., Kubo, H., Handa, N., Hanna, M., and Laronda, M.M. (2022). A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.918899"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.molmed.2020.11.003","article-title":"Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue","volume":"27","author":"Dolmans","year":"2021","journal-title":"Trends Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: A review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"117955811986735","DOI":"10.1177\/1179558119867357","article-title":"Ovarian Tissue Transplantation: Experience from Germany and Worldwide Efficacy","volume":"13","author":"Lotz","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humupd\/dmac003","article-title":"Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: A systematic review and individual patient data meta-analysis","volume":"28","author":"Khattak","year":"2022","journal-title":"Hum. Reprod. Update"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/humrep\/dead060","article-title":"Long-term follow-up to assess criteria for ovarian tissue cryopreservation for fertility preservation in young women and girls with cancer","volume":"38","author":"Duffin","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(04)17222-X","article-title":"Livebirth after orthotopic transplantation of cryopreserved ovarian tissue","volume":"364","author":"Donnez","year":"2004","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ramirez, T., and Pavone, M. (2024). Exploring the Frontiers of Ovarian Tissue Cryopreservation: A Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13154513"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dittrich, R., Lotz, L., Mueller, A., Hoffmann, I., Wachter, D.L., Amann, K.U., Beckmann, M.W., and Hildebrandt, T. (2013). Oncofertility: Combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod. Biol. Endocrinol., 11.","DOI":"10.1186\/1477-7827-11-19"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-014-0080-8","article-title":"Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes","volume":"7","author":"Dolmans","year":"2014","journal-title":"J. Ovarian Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.rbmo.2015.06.025","article-title":"Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield","volume":"31","author":"Hourvitz","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.rbmo.2017.03.007","article-title":"Outcomes of immature oocytes collected from ovarian tissue for cryopreservation in adult and prepubertal patients","volume":"34","author":"Fasano","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.maturitas.2015.06.031","article-title":"Fertility-sparing management of gynecological cancers","volume":"82","author":"Fastrez","year":"2015","journal-title":"Maturitas"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated with Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PPO.0000000000000346","article-title":"Cancer Burden in Adolescents and Young Adults: A Review of Epidemiological Evidence","volume":"24","author":"Trama","year":"2018","journal-title":"Cancer J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12282-024-01576-4","article-title":"French national survey on breast cancer care: Caregiver and patient views","volume":"31","author":"Lortal","year":"2024","journal-title":"Breast Cancer"},{"key":"ref_57","unstructured":"(2023). Panorama des Cancers en France \u00c9dition 2023, Institut national du Cancer (INCA)."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1188\/20.CJON.139-147","article-title":"Young Women with Breast Cancer: Treatment, Care, and Nursing Implications","volume":"24","author":"Corey","year":"2020","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO\u2013ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Cardoso","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Tesch, M.E., and Partridge, A.H. (2022). Treatment of Breast Cancer in Young Adults, American Society of Clinical Oncology Educational Book.","DOI":"10.1200\/EDBK_360970"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/clinpract13060127","article-title":"Breast Cancer and Fertility Preservation in Young Female Patients: A Systematic Review of the Literature","volume":"13","author":"Boutas","year":"2023","journal-title":"Clin. Pract."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Sonigo, C., Sermondade, N., Calvo, J., Benard, J., Sifer, C., and Grynberg, M. (2019). Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 4.","DOI":"10.1016\/j.eurox.2019.100049"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.07.017","article-title":"Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study","volume":"174","author":"Goldrat","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"103776","DOI":"10.1016\/j.breast.2024.103776","article-title":"Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up","volume":"77","author":"Dezellus","year":"2024","journal-title":"Breast"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: A multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod. Biomed. Online"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/14737140.2024.2372337","article-title":"Current practices in oncofertility counseling: Updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer","volume":"24","author":"Arecco","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jogoh.2018.05.008","article-title":"Breast cancer and ovarian tissue cryopreservation: Review of the literature","volume":"47","author":"Fleury","year":"2018","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_69","unstructured":"(2017). Femmes Porteuses d\u2019une Mutation de BRCA1 ou BRCA2: Recommandations de l\u2019INCA 2017, Institut National Du Cancer."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/fon-2017-0415","article-title":"Fertility preservation in BRCA-mutated women: When and how?","volume":"14","author":"Grynberg","year":"2018","journal-title":"Future Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clbc.2023.01.006","article-title":"Approaches to Fertility Preservation for Young Women with Breast Cancer","volume":"23","author":"Razeti","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","article-title":"BRCA1 Germline Mutations May Be Associated With Reduced Ovarian Reserve","volume":"102","author":"Wang","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/cncr.27952","article-title":"Comparison of age at natural menopause in BRCA1\/2 mutation carriers with a non\u2013clinic-based sample of women in northern California","volume":"119","author":"Lin","year":"2013","journal-title":"Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 Mutations with Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast\/Ovarian Cancer Risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canep.2017.04.001","article-title":"Hormonal and reproductive risk factors of papillary thyroid cancer: A population-based case-control study in France","volume":"48","author":"Leux","year":"2017","journal-title":"Cancer Epidemiol."},{"key":"ref_77","first-page":"174550572211363","article-title":"Thyroid cancer in women of reproductive age: Key issues for the clinical team","volume":"18","year":"2022","journal-title":"Womens Health"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Navarro, P., Rocher, S., Mir\u00f3-Mart\u00ednez, P., and Oltra-Crespo, S. (2022). Radioactive iodine and female fertility. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-07592-8"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","article-title":"Cervical cancer: Epidemiology","volume":"32","author":"Zhang","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"ref_80","first-page":"410","article-title":"R\u00e9seau fran\u00e7ais des registres de cancers Francim Cancer du col de l\u2019ut\u00e9rus en France: Tendances de l\u2019incidence et de la mortalit\u00e9 jusqu\u2019en 2018","volume":"22\u201323","author":"Hamers","year":"2019","journal-title":"Bull. Epid\u00e9miol. Hebd.\u2014BEH"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"103092","DOI":"10.1016\/j.critrevonc.2020.103092","article-title":"Fertility preservation in women with cervical cancer","volume":"154","author":"Somigliana","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humupd\/dmad002","article-title":"Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: A review","volume":"29","author":"Drechsel","year":"2023","journal-title":"Hum. Reprod. Update"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/ajh.26717","article-title":"Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management","volume":"97","author":"Ansell","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood-2021-146242","article-title":"Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp","volume":"138","author":"Santarsieri","year":"2021","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2022-166543","article-title":"Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy","volume":"140","author":"Santarsieri","year":"2022","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/humrep\/deab189","article-title":"Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling","volume":"36","author":"Decanter","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/bloodadvances.2021005557","article-title":"Hodgkin lymphoma and female fertility: A multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine","volume":"7","author":"Machet","year":"2023","journal-title":"Blood Adv."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12094-020-02483-8","article-title":"ABVD and BEACOPP regimens\u2019 effects on fertility in young males with Hodgkin lymphoma","volume":"23","author":"Amin","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ijc.34552","article-title":"Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway\u2014A population-based matched cohort study","volume":"153","author":"Entrop","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chu, Y., Liu, Y., Fang, X., Jiang, Y., Ding, M., Ge, X., Yuan, D., Lu, K., Li, P., and Li, Y. (2023). The epidemiological patterns of non-Hodgkin lymphoma: Global estimates of disease burden, risk factors, and temporal trends. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1059914"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"ref_94","unstructured":"Le Guyader-Peyrou, S., Defossez, G., Dantony, E., Mounier, M., Cornet, E., Uhry, Z., Cowppli-Bony, A., Maynadi\u00e9, M., Troussard, X., and Delafosse, P. (2019). Estimations Nationales de l\u2019Incidence et de la Mortalit\u00e9 par Cancer en France M\u00e9tropolitaine entre 1990 et 2018, Sant\u00e9 publique France."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"Znaor","year":"2019","journal-title":"Cancer Causes Control"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Minoia, C., Viviani, S., Silvestris, E., Palini, S., Parissone, F., De Palma, G., Fedina, A., Cormio, G., Guarini, A., and Gini, G. (2023). Fertility preservation and monitoring in adult patients diagnosed with lymphoma: Consensus-based practical recommendations by the Fondazione Italiana Linfomi & Societ\u00e0 Italiana della Riproduzione Umana. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1252433"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.jogoh.2020.101966","article-title":"Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation","volume":"50","author":"Bourdel","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_99","unstructured":"(2019). Conduites \u00e0 Tenir Initiales Devant des Patientes Atteintes d\u2019un Cancer \u00c9pith\u00e9lial de L\u2019ovaire, Institut National Du Cancer (INCA)."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gofs.2018.12.004","article-title":"Tumeurs \u00e9pith\u00e9liales de l\u2019ovaire: Pr\u00e9servation de la fertilit\u00e9. Article r\u00e9dig\u00e9 sur la base de la recommandation nationale de bonnes pratiques cliniques en canc\u00e9rologie intitul\u00e9e \u00ab Conduites \u00e0 tenir initiales devant des patientes atteintes d\u2019un cancer \u00e9pith\u00e9lial de l\u2019ovaire \u00bb \u00e9labor\u00e9e par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l\u2019\u00e9gide du CNGOF et labellis\u00e9e par l\u2019INCa","volume":"47","author":"Uzan","year":"2019","journal-title":"Gyn\u00e9col. Obs. Fertil. S\u00e9nol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/hmbci-2020-0026","article-title":"Fertility preservation in women with early ovarian cancer","volume":"43","author":"Necula","year":"2022","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejso.2013.11.028","article-title":"Conservative treatment of early stage ovarian cancer: Oncological and fertility outcomes","volume":"40","author":"Zapardiel","year":"2014","journal-title":"Eur. J. Surg. Oncol. EJSO"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejogrb.2013.06.039","article-title":"How many ovarian cancer patients are eligible for fertility-sparing surgery?","volume":"170","author":"Huber","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/cco-20-38","article-title":"Fertility-sparing treatment for epithelial ovarian cancer: A literature review","volume":"9","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Liu, D., Cai, J., Gao, A., Wang, Z., and Cai, L. (2020). Fertility sparing surgery vs. radical surgery for epithelial ovarian cancer: A meta-analysis of overall survival and disease-free survival. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06828-y"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Canlorbe, G., Chabbert-Buffet, N., and Uzan, C. (2021). Fertility-Sparing Surgery for Ovarian Cancer. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184235"},{"key":"ref_108","unstructured":"(2024, August 27). Tumeurs Germinales. Available online: https:\/\/www.ovaire-rare.org\/Referentiels\/Tumeurs_germinales.aspx."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bulcan.2017.10.032","article-title":"Pr\u00e9servation de la fertilit\u00e9, contraception et traitement hormonal de la m\u00e9nopause chez les femmes trait\u00e9es pour tumeurs malignes rares de l\u2019ovaire: Recommandations du r\u00e9seau national d\u00e9di\u00e9 aux cancers gyn\u00e9cologiques rares (TMRG\/GINECO)","volume":"105","author":"Selle","year":"2018","journal-title":"Bull. Cancer"},{"key":"ref_110","unstructured":"(2024, August 27). Tumeurs des Cordons Sexuels. Available online: https:\/\/www.ovaire-rare.org\/Referentiels\/Tumeurs_des_cordons_sexuels.aspx."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"ref_112","first-page":"29","article-title":"\u00c9pid\u00e9miologie des leuc\u00e9mies aigu\u00ebs","volume":"2015","author":"Troussard","year":"2015","journal-title":"Rev. Francoph. Lab."},{"key":"ref_113","first-page":"38","article-title":"Acute Myeloid Leukemia: A Review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"Rhode Isl. Med. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/cncr.30624","article-title":"Acute lymphoblastic leukemia in adolescents and young adults","volume":"123","author":"Rytting","year":"2017","journal-title":"Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/annonc\/mdz284","article-title":"Preserving fertility in female patients with hematological malignancies: A multidisciplinary oncofertility approach","volume":"30","author":"Salama","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.bulcan.2024.04.009","article-title":"Fertilit\u00e9 et greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques (SFGM-TC)","volume":"112","author":"Chevillon","year":"2025","journal-title":"Bull. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Waseh, S., and Lee, J.B. (2023). Advances in melanoma: Epidemiology, diagnosis, and prognosis. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1268479"},{"key":"ref_118","unstructured":"(2024, August 28). Epid\u00e9miologie des Cancers Cutan\u00e9s-D\u00e9tection Pr\u00e9coce des Cancers de la Peau. Available online: https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/Depistage-et-detection-precoce\/Detection-precoce-des-cancers-de-la-peau\/Epidemiologie."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"128","DOI":"10.23736\/S2784-8671.24.07811-3","article-title":"Melanoma epidemiology in Europe: What is new?","volume":"159","author":"Nurla","year":"2024","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"100248","DOI":"10.1016\/j.esmoop.2021.100248","article-title":"Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy","volume":"6","author":"Hassel","year":"2021","journal-title":"ESMO Open"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"Geurts","year":"2023","journal-title":"Lancet"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10147-021-02084-7","article-title":"Adolescent and young adult brain tumors: Current topics and review","volume":"27","author":"Yamasaki","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/nop\/npw005","article-title":"Fertility preservation in primary brain tumor patients","volume":"4","author":"Stone","year":"2017","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.11604\/pamj.2013.14.104.1285","article-title":"Aspects \u00e9pid\u00e9miologiques, diagnostiques et th\u00e9rapeutiques des ost\u00e9osarcomes de l\u2019enfant au CHU Aristide le Dantec de Dakar: \u00c0 propos de 16 cas","volume":"14","author":"Ndour","year":"2013","journal-title":"Pan Afr. Med. J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e28352","DOI":"10.1002\/pbc.28352","article-title":"Osteosarcoma","volume":"68","author":"Eaton","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/jayao.2023.0185","article-title":"A Systematic Review of the Gonadotoxicity of Osteosarcoma and Ewing\u2019s Sarcoma Chemotherapies in Postpubertal Females and Males","volume":"13","author":"Weidlinger","year":"2024","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO\u2013EURACAN\u2013GENTURIS\u2013ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","article-title":"Osteosarcoma","volume":"21","author":"Ritter","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ejca.2013.01.032","article-title":"Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination","volume":"49","author":"Greve","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pbc.25304","article-title":"Ovarian function in female survivors after multimodal Ewing sarcoma therapy","volume":"62","author":"Raciborska","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/humrep\/deq121","article-title":"Occasional involvement of the ovary in Ewing sarcoma","volume":"25","author":"Abir","year":"2010","journal-title":"Hum. Reprod."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e27941","DOI":"10.1002\/pbc.27941","article-title":"Colorectal cancer in adolescents and young adults: Defining a growing threat","volume":"66","author":"Levine","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/DCR.0000000000001687","article-title":"Fertility and Endocrine Preservation in the Management of Colorectal Cancer in Women","volume":"63","author":"Hayslip","year":"2020","journal-title":"Dis. Colon Rectum"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Vitale, F., and Dolmans, M.M. (2024). Comprehensive Review of In Vitro Human Follicle Development for Fertility Restoration: Recent Achievements, Current Challenges, and Future Optimization Strategies. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061791"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:51:18Z","timestamp":1760028678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":136,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14061912"],"URL":"https:\/\/doi.org\/10.3390\/jcm14061912","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}